S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

AVTE Aerovate Therapeutics Inc

2.46

-0.01 (-0.40%)

Last Updated: 11:35:53

Delayed by 15 minutes

Form S-4 - Registration of securities, business combinations

0001104659-24-124782.txt

Aerovate Therapeutics (NASDAQ:AVTE)
Historical Stock Chart
From Jan 2025 to Feb 2025

Click Here for more Aerovate Therapeutics Charts.

Aerovate Therapeutics (NASDAQ:AVTE)
Historical Stock Chart
From Feb 2024 to Feb 2025

Click Here for more Aerovate Therapeutics Charts.

Aerovate Therapeutics Inc News

Form 425 - Prospectuses and communications, business combinations
Tuesday 4 February 2025 (6 days ago) • Edgar (US Regulatory)

Form 425 - Prospectuses and communications, business combinations
Friday 24 January 2025 (2 weeks ago) • Edgar (US Regulatory)

Form S-4/A - Registration of securities, business combinations: [Amend]
Wednesday 22 January 2025 (3 weeks ago) • Edgar (US Regulatory)

Form 425 - Prospectuses and communications, business combinations
Monday 13 January 2025 (4 weeks ago) • Edgar (US Regulatory)

Form S-4 - Registration of securities, business combinations
Tuesday 3 December 2024 (2 months ago) • Edgar (US Regulatory)

Form RW - Registration Withdrawal Request
Monday 25 November 2024 (3 months ago) • Edgar (US Regulatory)

Form 425 - Prospectuses and communications, business combinations
Monday 18 November 2024 (3 months ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Tuesday 12 November 2024 (3 months ago) • Edgar (US Regulatory)

Kuehn Law Encourages OB, AVTE, B, and MNTX Investors to Contact Law Firm
Friday 1 November 2024 (3 months ago) • PR Newswire (US)

Form 425 - Prospectuses and communications, business combinations
Thursday 31 October 2024 (3 months ago) • Edgar (US Regulatory)

Form 425 - Prospectuses and communications, business combinations
Thursday 31 October 2024 (3 months ago) • Edgar (US Regulatory)

Form 425 - Prospectuses and communications, business combinations
Thursday 31 October 2024 (3 months ago) • Edgar (US Regulatory)

More Aerovate Therapeutics Inc News Articles

Maven Income And Growth ...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions